Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.
Kerr DJ., Maughan T., Newlands E., Rustin G., Bleehen NM., Lewis C., Kaye SB.
Flavone acetic acid (FAA), 8.6 gm-2 has been administered by 6h intravenous infusion to 19 patients with advanced colorectal carcinoma and 15 patients with advanced malignant melanoma. The drug associated toxicity was generally mild and as predicted from the phase I study. No responses were seen in either disease.